Articles related to STOMACH CANCER

This review highlights the importance of evaluating the duration of proton pump inhibitor therapy in light of its association with an increased risk of stomach cancer. Long-term use, defined as one year or more, can significantly heighten this risk, emphasizing the need for judicious use of these medications.

This article distills key aspects of stomach cancer into patient-friendly language, highlighting the critical role of early detection and lifestyle interventions in managing this condition.

In a recent study, researchers found that, although pembrolizumab increased the pathological complete response in gastric cancer patients, it did not significantly improve event-free survival.

In the complex landscape of gastric intestinal metaplasia, understanding the risk factors and histological differences is key to optimizing patient outcomes. This article sheds light on the critical role of targeted surveillance in high-risk patients.

This case study highlights the critical role of early diagnosis in managing alopecia neoplastica, a rare but significant indicator of metastatic spread in cancer patients. Learn more about the diagnostic challenges and implications for treatment.

The field of gastric and esophageal cancer treatment is witnessing remarkable advancements through targeted therapies and immunotherapies. Explore the latest clinical trials and discoveries that are redefining the standard of care for these traditionally difficult-to-treat cancers.